INCY
Incyte Corporation
NASDAQ: INCY · HEALTHCARE · BIOTECHNOLOGY
$99.10
+1.39% today
Updated 2026-04-29
Market cap
$19.80B
P/E ratio
14.00
P/S ratio
3.69x
EPS (TTM)
$7.08
Dividend yield
—
52W range
$58 – $112
Volume
1.6M
Incyte Corporation (INCY) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $27.64M | $34.44M | $3.92M | $9.27M | $169.88M | $94.45M | $297.06M | $354.95M | $511.50M | $753.75M | $1.11B | $1.54B | $1.88B | $2.16B | $2.67B | $2.99B | $3.39B | $3.70B | $4.24B | $5.14B |
| Revenue growth (YoY) | — | +24.6% | -88.6% | +136.4% | +1733.5% | -44.4% | +214.5% | +19.5% | +44.1% | +47.4% | +46.7% | +38.9% | +22.5% | +14.7% | +23.5% | +12.0% | +13.7% | +8.9% | +14.8% | +21.2% |
| Cost of revenue | $98.00M | $116.30M | $161.31M | $145.54M | $155.11M | $234.73M | $30.14M | $29.84M | $44.42M | $49.41M | $104.01M | $110.16M | $127.59M | $147.28M | $161.63M | $187.34M | $253.35M | $315.15M | $377.72M | $438.72M |
| Gross profit | $27.64M | $34.44M | $3.92M | $9.27M | $169.88M | $94.45M | $266.92M | $325.11M | $467.08M | $704.34M | $1.00B | $1.43B | $1.75B | $2.01B | $2.51B | $2.80B | $3.14B | $3.38B | $3.86B | $4.70B |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 89.9% | 91.6% | 91.3% | 93.4% | 90.6% | 92.8% | 93.2% | 93.2% | 93.9% | 93.7% | 92.5% | 91.5% | 91.1% | 91.5% |
| R&D | $80.19M | $91.93M | $133.29M | $102.75M | $99.39M | $178.71M | $210.39M | $260.44M | $347.52M | $479.51M | $581.86M | $1.33B | $1.20B | $1.15B | $2.22B | $1.46B | $1.59B | $1.63B | $2.61B | $1.98B |
| SG&A | $16.91M | $15.24M | $17.07M | $27.58M | $32.33M | $58.22M | $85.36M | $109.98M | $165.77M | $196.61M | $303.25M | $366.41M | $424.33M | $453.41M | $516.90M | $739.60M | $1.00B | $1.16B | $1.22B | $1.38B |
| Operating income | $-73.96M | $-85.48M | $-159.52M | $-137.76M | $13.67M | $-143.18M | $1.15M | $-16.10M | $-4.80M | $50.65M | $164.02M | $-235.68M | $155.40M | $421.69M | $-240.29M | $637.54M | $599.56M | $651.77M | $80.14M | $1.34B |
| Operating margin | -267.6% | -248.2% | -4070.3% | -1486.9% | 8.0% | -151.6% | 0.4% | -4.5% | -0.9% | 6.7% | 14.8% | -15.3% | 8.3% | 19.5% | -9.0% | 21.3% | 17.7% | 17.6% | 1.9% | 26.1% |
| EBITDA | $-48.84M | $-49.89M | $-140.91M | $-163.06M | $35.96M | $-116.19M | $31.89M | $-14.99M | $39.96M | $98.04M | $204.57M | $-253.21M | $171.86M | $543.18M | $-178.24M | $630.20M | $599.64M | $919.43M | $408.16M | $1.76B |
| EBITDA margin | -176.7% | -144.8% | -3595.6% | -1759.9% | 21.2% | -123.0% | 10.7% | -4.2% | 7.8% | 13.0% | 18.5% | -16.5% | 9.1% | 25.2% | -6.7% | 21.1% | 17.7% | 24.9% | 9.6% | 34.2% |
| EBIT | $-56.26M | $-62.85M | $-153.98M | $-179.75M | $11.48M | $-143.18M | $1.91M | $-44.20M | $-1.45M | $53.16M | $146.15M | $-305.39M | $116.89M | $488.65M | $-230.04M | $572.35M | $531.78M | $836.77M | $318.91M | $1.67B |
| Interest expense | $17.91M | $24.03M | $24.94M | $32.13M | $43.32M | $43.82M | $46.06M | $38.65M | $47.09M | $45.60M | $38.74M | $6.90M | $1.54M | $1.85M | $2.17M | $1.91M | $2.67M | $2.55M | $2.28M | $2.43M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-74.17M | $-86.88M | $-178.92M | $-211.87M | $-31.85M | $-186.54M | $-44.32M | $-83.15M | $-48.48M | $6.53M | $104.22M | $-313.14M | $109.49M | $446.91M | $-295.70M | $948.58M | $340.66M | $597.60M | $32.62M | $1.29B |
| Net income growth (YoY) | — | -17.1% | -105.9% | -18.4% | +85.0% | -485.8% | +76.2% | -87.6% | +41.7% | +113.5% | +1495.8% | -400.5% | +135.0% | +308.2% | -166.2% | +420.8% | -64.1% | +75.4% | -94.5% | +3845.0% |
| Profit margin | -268.3% | -252.3% | -4565.5% | -2286.8% | -18.7% | -197.5% | -14.9% | -23.4% | -9.5% | 0.9% | 9.4% | -20.4% | 5.8% | 20.7% | -11.1% | 31.8% | 10.0% | 16.2% | 0.8% | 25.0% |